Functional polymorphisms in Nrf2: Implications for human disease

Free Radical Biology and Medicine

Volumn 88, Issue Part B, 2015, Pages 362-372

  Cho, Hye Youn ^a   Marzec, Jacqui ^a   Kleeberger, Steven R ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Antioxidant response element; Complex disease; Genetic; Genome wide association; Mouse; Mutations; Promoter; Somatic

Indexed keywords

TRANSCRIPTION FACTOR NRF2;

ALLELE; ARTICLE; CARDIOVASCULAR DISEASE; DEGENERATIVE DISEASE; DISEASES; EXOME; GASTROINTESTINAL DISEASE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HAPLOTYPE; HAPLOTYPE MAP; HUMAN; NEOPLASM; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; RESPIRATORY TRACT DISEASE; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; ANIMAL; GENETICS; MOUSE; MUTATION;

ANIMALS; HUMANS; MICE; MUTATION; NEOPLASMS; NF-E2-RELATED FACTOR 2; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84970971321     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2015.06.012     Document Type: Review

References (83)

1. J.Y. Chan, M.C. Cheung, P. Moi, K. Chan, and Y.W. Kan Chromosomal localization of the human NF-E2 family of bZIP transcription factors by fluorescence in situ hybridization Hum Genet 95 1995 265 269
2. K. Itoh, K. Igarashi, N. Hayashi, M. Nishizawa, and M. Yamamoto Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maf family proteins Mol Cell Biol 15 1995 4184 4193
3. W.O. Osburn, and T.W. Kensler Nrf2 signaling: an adaptive response pathway for protection against environmental toxic insults Mutation research 659 2008 31 39
4. D. Papp, K. Lenti, D. Modos, D. Fazekas, Z. Dul, and et al. The Nrf2-related interactome and regulome contain multifunctional proteins and fine-tuned autoregulatory loops FEBS letters 586 2012 1795 1802
5. X. Wang, D.J. Tomso, B.N. Chorley, H.Y. Cho, V.G. Cheung, and et al. Identification of polymorphic antioxidant response elements in the human genome Hum Mol Genet 16 2007 1188 1200
6. D. Malhotra, E. Portales-Casamar, A. Singh, S. Srivastava, D. Arenillas, and et al. Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis Nucleic Acids Res 38 2010 5718 5734
7. K. Itoh, N. Wakabayashi, Y. Katoh, T. Ishii, K. Igarashi, and et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain Genes Dev 13 1999 76 86
8. A. Kobayashi, M.I. Kang, H. Okawa, M. Ohtsuji, Y. Zenke, and et al. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2 Mol Cell Biol 24 2004 7130 7139
9. K. Taguchi, H. Motohashi, and M. Yamamoto Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution Genes to cells: devoted to molecular & cellular mechanisms 16 2011 123 140
10. S. Chowdhry, Y. Zhang, M. McMahon, C. Sutherland, A. Cuadrado, and et al. Nrf2 is controlled by two distinct beta-TrCP recognition motifs in its Neh6 domain, one of which can be modulated by GSK-3 activity Oncogene 32 2013 3765 3781
11. K. Chan, R. Lu, J.C. Chang, and Y.W. Kan Nrf2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development Proc Natl Acad Sci U S A 93 1996 13943 13948
12. K. Itoh, T. Chiba, S. Takahashi, T. Ishii, K. Igarashi, and et al. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements Biochem Biophys Res Commun 236 1997 313 322
13. F. Martin, J.M. van Deursen, R.A. Shivdasani, C.W. Jackson, A.G. Troutman, and et al. Erythroid maturation and globin gene expression in mice with combined deficiency of NF-E2 and nrf-2 Blood 91 1998 3459 3466
14. H.Y. Cho, A.E. Jedlicka, W. Gladwell, J. Marzec, Z.R. McCaw, and et al. Association of Nrf2 polymorphism haplotypes with acute lung injury phenotypes in inbred strains of mice Antioxid Redox Signal 22 2015 325 338
15. H.Y. Cho, A.E. Jedlicka, S.P. Reddy, L.Y. Zhang, T.W. Kensler, and et al. Linkage analysis of susceptibility to hyperoxia. Nrf2 is a candidate gene Am J Respir Cell Mol Biol 26 2002 42 51
16. S.C. Lo, X. Li, M.T. Henzl, L.J. Beamer, and M. Hannink Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling The EMBO journal 25 2006 3605 3617
17. J. Maher, and M. Yamamoto The rise of antioxidant signaling - the evolution and hormetic actions of Nrf2 Toxicology and applied pharmacology 244 2010 4 15
18. T. Yamamoto, K. Yoh, A. Kobayashi, Y. Ishii, S. Kure, and et al. Identification of polymorphisms in the promoter region of the human Nrf2 gene Biochem Biophys Res Commun 321 2004 72 79
19. H. Fukushima-Uesaka, Y. Saito, K. Maekawa, N. Kamatani, H. Kajio, and et al. Genetic variations and haplotype structures of transcriptional factor Nrf2 and its cytosolic reservoir protein Keap1 in Japanese Drug metabolism and pharmacokinetics 22 2007 212 219
20. M. von Otter, P. Bergstrom, A. Quattrone, E. De Marco, G. Annesi, and et al. Genetic associations of Nrf2-encoding NFE2L2 variants with Parkinson inverted question marks disease inverted question mark a multicenter study BMC Med Genet 15 2014 131
21. J.M. Marzec, J.D. Christie, S.P. Reddy, A.E. Jedlicka, H. Vuong, and et al. Functional polymorphisms in the transcription factor Nrf2 in humans increase the risk of acute lung injury Faseb J 21 2007 2237 2246
22. D.S. O'Mahony, B.J. Glavan, T.D. Holden, C. Fong, R.A. Black, and et al. Inflammation and immune-related candidate gene associations with acute lung injury susceptibility and severity: a validation study PloS one 7 2012 e51104
23. H. Masuko, T. Sakamoto, Y. Kaneko, H. Iijima, T. Naito, and et al. Lower FEV1 in non-COPD, nonasthmatic subjects: association with smoking, annual decline in FEV1, total IgE levels, and TSLP genotypes International journal of chronic obstructive pulmonary disease 6 2011 181 189
24. H. Masuko, T. Sakamoto, Y. Kaneko, H. Iijima, T. Naito, and et al. An interaction between Nrf2 polymorphisms and smoking status affects annual decline in FEV1: a longitudinal retrospective cohort study BMC medical genetics 12 2011 97
25. H. Sasaki, A. Suzuki, M. Shitara, Y. Hikosaka, K. Okuda, and et al. Polymorphisms of Nrf2 gene correlated with decreased FEV1 in lung cancers of smokers Biomedical reports 1 2013 484 488
26. M. Siedlinski, D.S. Postma, J.M. Boer, G. van der Steege, J.P. Schouten, and et al. Level and course of FEV1 in relation to polymorphisms in NFE2L2 and Keap1 in the general population Respiratory research 10 2009 73
27. S.M. Figarska, J.M. Vonk, and H.M. Boezen NFE2L2 polymorphisms, mortality, and metabolism in the general population Physiological genomics 46 2014 411 417
28. I. Ungvari, E. Hadadi, V. Virag, A. Nagy, A. Kiss, and et al. Relationship between air pollution, NFE2L2 gene polymorphisms and childhood asthma in a Hungarian population Journal of community genetics 3 2012 25 33
29. C. Canova, C. Dunster, F.J. Kelly, C. Minelli, P.L. Shah, and et al. PM10-induced hospital admissions for asthma and chronic obstructive pulmonary disease: the modifying effect of individual characteristics Epidemiology 23 2012 607 615
30. A.J. Henderson, R.B. Newson, M. Rose-Zerilli, S.M. Ring, J.W. Holloway, and et al. Maternal Nrf2 and gluthathione-S-transferase polymorphisms do not modify associations of prenatal tobacco smoke exposure with asthma and lung function in school-aged children Thorax 65 2010 897 902
31. S.O. Shaheen, R.B. Newson, S.M. Ring, M.J. Rose-Zerilli, J.W. Holloway, and et al. Prenatal and infant acetaminophen exposure, antioxidant gene polymorphisms, and childhood asthma The Journal of allergy and clinical immunology 126 1141-1148 2010 e1147
32. V. Sampath, J.S. Garland, D. Helbling, D. Dimmock, N.P. Mulrooney, and et al. Antioxidant response genes sequence variants and BPD susceptibility in VLBW infants Pediatr Res 77 2015 477 483
33. Y. Shimoyama, Y. Mitsuda, Y. Tsuruta, N. Hamajima, and T. Niwa Polymorphism of Nrf2, an antioxidative gene, is associated with blood pressure and cardiovascular mortality in hemodialysis patients International journal of medical sciences 11 2014 726 731
34. J. Bouligand, O. Cabaret, M. Canonico, C. Verstuyft, L. Dubert, and et al. Effect of NFE2L2 genetic polymorphism on the association between oral estrogen therapy and the risk of venous thromboembolism in postmenopausal women Clin Pharmacol Ther 89 2011 60 64
35. B. Wang, M. Liu, W. Yan, J. Mao, D. Jiang, and et al. Association of SNPs in genes involved in folate metabolism with the risk of congenital heart disease The journal of maternal-fetal & neonatal medicine: the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 26 2013 1768 1777
36. E.D. Marczak, J. Marzec, D.C. Zeldin, S.R. Kleeberger, N.J. Brown, and et al. Polymorphisms in the transcription factor Nrf2 and forearm vasodilator responses in humans Pharmacogenetics and genomics 22 2012 620 628
37. T. Arisawa, T. Tahara, T. Shibata, M. Nagasaka, M. Nakamura, and et al. The influence of promoter polymorphism of nuclear factor-erythroid 2-related factor 2 gene on the aberrant DNA methylation in gastric epithelium Oncol Rep 19 2008 211 216
38. T. Arisawa, T. Tahara, T. Shibata, M. Nagasaka, M. Nakamura, and et al. Nrf2 gene promoter polymorphism and gastric carcinogenesis Hepato-gastroenterology 55 2008 750 754
39. T. Arisawa, T. Tahara, T. Shibata, M. Nagasaka, M. Nakamura, and et al. Nrf2 gene promoter polymorphism is associated with ulcerative colitis in a Japanese population Hepato-gastroenterology 55 2008 394 397
40. M. von Otter, S. Landgren, S. Nilsson, D. Celojevic, P. Bergstrom, and et al. Association of Nrf2-encoding NFE2L2 haplotypes with Parkinson's disease BMC medical genetics 11 2010 36
41. M. von Otter, S. Landgren, S. Nilsson, M. Zetterberg, D. Celojevic, and et al. Nrf2-encoding NFE2L2 haplotypes influence disease progression but not risk in Alzheimer's disease and age-related cataract Mechanisms of ageing and development 131 2010 105 110
42. P. Bergstrom, M. von Otter, S. Nilsson, A.C. Nilsson, M. Nilsson, and et al. Association of NFE2L2 and Keap1 haplotypes with amyotrophic lateral sclerosis Amyotrophic lateral sclerosis & frontotemporal degeneration 15 2014 130 137
43. Y. Okano, U. Nezu, Y. Enokida, M.T. Lee, H. Kinoshita, and et al. SNP (-617C>A) in ARE-like loci of the Nrf2 gene: a new biomarker for prognosis of lung adenocarcinoma in Japanese non-smoking women PloS one 8 2013 e73794
44. T. Khunluck, V. Kukongviriyapan, A. Puapairoj, N. Khuntikeo, L. Senggunprai, and et al. Association of Nrf2 polymorphism with cholangiocarcinoma prognosis in Thai patients Asian Pacific journal of cancer prevention: APJCP 15 2014 299 304
45. J.M. Hartikainen, M. Tengstrom, V.M. Kosma, V.L. Kinnula, A. Mannermaa, and et al. Genetic polymorphisms and protein expression of Nrf2 and Sulfiredoxin predict survival outcomes in breast cancer Cancer research 72 2012 5537 5546
46. C.C. Hong, C.B. Ambrosone, J. Ahn, J.Y. Choi, M.L. McCullough, and et al. Genetic variability in iron-related oxidative stress pathways (Nrf2, NQ01, NOS3, and HO-1), iron intake, and risk of postmenopausal breast cancer Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 16 2007 1784 1794
47. C. Xing, A.L. Sestak, J.A. Kelly, K.L. Nguyen, G.R. Bruner, and et al. Localization and replication of the systemic lupus erythematosus linkage signal at 4p16: interaction with 2p11, 12q24 and 19q13 in European Americans Human genetics 120 2007 623 631
48. E.J. Cordova, R. Velazquez-Cruz, F. Centeno, V. Baca, and L. Orozco The Nrf2 gene variant, -653G/A, is associated with nephritis in childhood-onset systemic lupus erythematosus Lupus 19 2010 1237 1242
49. C.P. Guan, M.N. Zhou, A.E. Xu, K.F. Kang, J.F. Liu, and et al. The susceptibility to vitiligo is associated with NF-E2-related factor2 (Nrf2) gene polymorphisms: a study on Chinese Han population Experimental dermatology 17 2008 1059 1062
50. E. Synowiec, T. Sliwinski, K. Danisz, J. Blasiak, A. Sklodowska, and et al. Association between polymorphism of the NQO1, NOS3 and NFE2L2 genes and AMD Frontiers in bioscience 18 2013 80 90
51. M.R. Stratton, P.J. Campbell, and P.A. Futreal The cancer genome Nature 458 2009 719 724
52. A.I. Ojesina, L. Lichtenstein, S.S. Freeman, C.S. Pedamallu, I. Imaz-Rosshandler, and et al. Landscape of genomic alterations in cervical carcinomas Nature 506 2014 371 375
53. Y.B. Gao, Z.L. Chen, J.G. Li, X.D. Hu, X.J. Shi, and et al. Genetic landscape of esophageal squamous cell carcinoma Nat Genet 46 2014 1097 1102
54. M. Eichenmuller, F. Trippel, M. Kreuder, A. Beck, T. Schwarzmayr, and et al. The genomic landscape of hepatoblastoma and their progenies with HCC-like features J Hepatol 61 2014 1312 1320
55. T. Shibata, T. Ohta, K.I. Tong, A. Kokubu, R. Odogawa, and et al. Cancer related mutations in Nrf2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy Proc Natl Acad Sci U S A 105 2008 13568 13573
56. A. Singh, V. Misra, R.K. Thimmulappa, H. Lee, S. Ames, and et al. Dysfunctional Keap1-Nrf2 interaction in non-small-cell lung cancer PLoS Med 3 2006 e420
57. N.Y. Yap, K.L. Ng, T.A. Ong, J. Pailoor, G.C. Gobe, and et al. Clinical prognostic factors and survival outcome in renal cell carcinoma patients - a malaysian single centre perspective Asian Pac J Cancer Prev 14 2013 7497 7500
58. Cancer Genome Atlas Research N Comprehensive genomic characterization of squamous cell lung cancers Nature 489 2012 519 525
59. T. Ohta, K. Iijima, M. Miyamoto, I. Nakahara, H. Tanaka, and et al. Loss of Keap1 function activates Nrf2 and provides advantages for lung cancer cell growth Cancer Res 68 2008 1303 1309
60. B. Padmanabhan, K.I. Tong, T. Ohta, Y. Nakamura, M. Scharlock, and et al. Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer Mol Cell 21 2006 689 700
61. T. Shibata, A. Kokubu, M. Gotoh, H. Ojima, T. Ohta, and et al. Genetic alteration of Keap1 confers constitutive Nrf2 activation and resistance to chemotherapy in gallbladder cancer Gastroenterology 135 2008 1358 1368, 1368 e1351-1354
62. N.J. Yoo, H.R. Kim, Y.R. Kim, C.H. An, and S.H. Lee Somatic mutations of the Keap1 gene in common solid cancers Histopathology 60 2012 943 952
63. Y. Hu, Y. Ju, D. Lin, Z. Wang, Y. Huang, and et al. Mutation of the Nrf2 gene in non-small cell lung cancer Molecular biology reports 39 2012 4743 4747
64. Y.R. Kim, J.E. Oh, M.S. Kim, M.R. Kang, S.W. Park, and et al. Oncogenic Nrf2 mutations in squamous cell carcinomas of oesophagus and skin J Pathol 220 2010 446 451
65. H. Sasaki, A. Suzuki, M. Shitara, Y. Hikosaka, K. Okuda, and et al. Genotype analysis of the Nrf2 gene mutation in lung cancer Int J Mol Med 31 2013 1135 1138
66. Y. Song, L. Li, Y. Ou, Z. Gao, E. Li, and et al. Identification of genomic alterations in oesophageal squamous cell cancer Nature 509 2014 91 95
67. Y. Totoki, K. Tatsuno, S. Yamamoto, Y. Arai, F. Hosoda, and et al. High-resolution characterization of a hepatocellular carcinoma genome Nat Genet 43 2011 464 469
68. O. Kalinina, A. Marchio, A.I. Urbanskii, A.B. Tarkova, K. Rebbani, and et al. Somatic changes in primary liver cancer in Russia: a pilot study Mutat Res 755 2013 90 99
69. H.Y. Cho Genomic structure and variation of nuclear factor (erythroid-derived 2)-like 2 Oxid Med Cell Longev 2013 2013 286524
70. A. Singh, M. Bodas, N. Wakabayashi, F. Bunz, and S. Biswal Gain of Nrf2 function in non-small-cell lung cancer cells confers radioresistance Antioxidants & redox signaling 13 2010 1627 1637
71. H. Sasaki, M. Shitara, K. Yokota, Y. Hikosaka, S. Moriyama, and et al. Increased Nrf2 gene (NFE2L2) copy number correlates with mutations in lung squamous cell carcinomas Molecular medicine reports 6 2012 391 394
72. H. Sasaki, M. Shitara, K. Yokota, Y. Hikosaka, S. Moriyama, and et al. RagD gene expression and Nrf2 mutations in lung squamous cell carcinomas Oncology letters 4 2012 1167 1170
73. A.K. Bauer, H.Y. Cho, L. Miller-Degraff, C. Walker, K. Helms, and et al. Targeted deletion of nrf2 reduces urethane-induced lung tumor development in mice PloS one 6 2011 e26590
74. H.Y. Cho, and S.R. Kleeberger Nrf2 protects against airway disorders Toxicology and applied pharmacology 244 2010 43 56
75. M. Siedlinski, D.S. Postma, J.M. Boer, G. van der Steege, J.P. Schouten, and et al. Level and course of FEV1 in relation to polymorphisms in NFE2L2 and Keap1 in the general population Respir Res 10 2009 73
76. T. Arisawa, T. Tahara, T. Shibata, M. Nagasaka, M. Nakamura, and et al. The relationship between Helicobacter pylori infection and promoter polymorphism of the Nrf2 gene in chronic gastritis International journal of molecular medicine 19 2007 143 148
77. J.M. Hartikainen, M. Tengstrom, V.M. Kosma, V.L. Kinnula, A. Mannermaa, and et al. Genetic polymorphisms and protein expression of Nrf2 and Sulfiredoxin predict survival outcomes in breast cancer Cancer Res 72 2012 5537 5546
78. C.P. Guan, M.N. Zhou, A.E. Xu, K.F. Kang, J.F. Liu, and et al. The susceptibility to vitiligo is associated with NF-E2-related factor2 (Nrf2) gene polymorphisms: a study on Chinese Han population Exp Dermatol 17 2008 1059 1062
79. T. Shibata, A. Kokubu, S. Saito, M. Narisawa-Saito, H. Sasaki, and et al. Nrf2 mutation confers malignant potential and resistance to chemoradiation therapy in advanced esophageal squamous cancer Neoplasia 13 2011 864 873
80. A.M. Tanase, A. Marchio, T. Dumitrascu, S. Dima, V. Herlea, and et al. Mutation spectrum of hepatocellular carcinoma from eastern-European patients betrays the impact of a complex exposome J Expo Sci Environ Epidemiol 2014
81. D.S. Tan, W. Wang, H.S. Leong, P.H. Sew, D.P. Lau, and et al. Tongue carcinoma infrequently harbor common actionable genetic alterations BMC Cancer 14 2014 679
82. S.Z. Abildstrom, B.T. Jensen, E. Agner, C. Torp-Pedersen, O. Nyvad, and et al. Heart rate versus heart rate variability in risk prediction after myocardial infarction J Cardiovasc Electrophysiol 14 2003 168 173
83. A. Ooi, K. Dykema, A. Ansari, D. Petillo, J. Snider, and et al. CUL3 and Nrf2 mutations confer an Nrf2 activation phenotype in a sporadic form of papillary renal cell carcinoma Cancer Res 73 2013 2044 2051